EFPIA Homepage, pharmaceutical industry data.#Pharmaceutical #industry #data


Posted On Jan 18 2018 by

Illness never sleeps, so neither do we

OECD data shows long-term care drive health expenditure, health outcome variations persist

The report provides an overview of overall health status in OECD countries, and how medical progress has contributed to longer and healthier lives for.

EFPIA welcomes the future location of the EMA decision has been made; now the focus must be on transition.

EFPIA congratulates Amsterdam on being selected as the new location for the EMA

Incentives, IP and smaller companies – Case story: Vaxeal

How Vaxeal wants to change patients’ lives by improving health outcomes

1st European Alliance for Personalised Medicine Congress

Personalising Your Health: A Global Imperative!

SafeSciMET Courses on regulatory requirements and guidelines

A course to provide participants with a comprehensive overview of the required in vitro and in vivo nonclinical studies, strategies for the development.

War on Cancer – A patient’s journey

3rd annual conference organised by The Economist Events

Featured Articles

Pharmaceutical industry data

Featured article

Incentivising Research in Areas of High Unmet Medical Need: Lilly’s Alzheimer’s Quest

With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression, avoiding illness and reducing overall costs for healthcare systems

  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data

  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data
  • Pharmaceutical industry data

Last Updated on: January 18th, 2018 at 6:10 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *